CTOs on the Move


 
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.viz.ai

  • San Francisco, CA USA
  • Phone: 866.849.4980

Executives

Name Title Contact Details
Gad Sakin
CTO Profile

Funding

Viz raised $21M on 07/18/2018
Viz raised $50M on 10/23/2019
Viz raised $71M on 03/17/2021

Similar Companies

Archer OpTx Inc

Archer OpTx Inc is a Rowlett, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Anthogyr

Anthogyr is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VisCardia

VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.

EY LABS

EY LABS is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NOBLE MEDICAL

NOBLE MEDICAL, Inc. is a Brookfield, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.